diprofos has been researched along with Immunoglobulin G4-Related Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Fei, Y; Gong, Y; Li, J; Li, Y; Lin, W; Liu, X; Liu, Y; Liu, Z; Peng, L; Shen, M; Shi, Q; Wang, M; Zeng, X; Zhang, F; Zhang, P; Zhang, W; Zhang, X; Zhao, Y; Zhou, J | 1 |
1 trial(s) available for diprofos and Immunoglobulin G4-Related Disease
| Article | Year |
|---|---|
Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial.
Topics: Adrenal Cortex Hormones; Adult; Autoimmunity; Betamethasone; Biomarkers; China; Chromones; Drug Combinations; Drug Therapy, Combination; Female; Humans; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Male; Metabolome; Middle Aged; Prospective Studies; Remission Induction; Severity of Illness Index; Sulfonamides; Time Factors; Treatment Outcome | 2019 |